In an alopecia areata trial, a novel bifunctional therapy that blocks signaling of the interleukin-7 and TSLP pathways ...

Oral ivarmacitinib, administered 4 mg or 8 mg once daily, significantly induced hair regrowth at 24 weeks vs. placebo in ...

Pfizer’s JAK/TEC inhibitor Litfulo has been recommended for NHS use as a treatment for hair loss caused by severe alopecia areata, the first drug therapy for a condition that affects around ...

Pfizer said that Litfulo (ritlecitinib) is the first alopecia areata therapy to be cleared for use in adolescents in the EU. JAK1/2 inhibitor Olumiant (baricitinib) was the first drug to be ...

A drug which it is hoped ... wanting to understand more about this new medicine. "We hope that Litfulo will be a treatment option for many patients with severe alopecia areata across the whole ...

Thirty-six weeks of once-daily, oral baricitinib was associated with greater hair regrowth on the scalp, eyebrows and ...

When diagnosing drug-induced alopecia, a doctor will take a complete medical history that takes into account the following factors: any new medications that the person is taking, including over ...

In a new JAMA Dermatology study, scientists at King’s found that changes in two parts of the genome work together to influence alopecia risk. Frontal fibrosing alopecia (FFA ... basis of the condition ...

Arcutis Biotherapeutics is advancing in alopecia areata and atopic dermatitis with ZORYVE. Learn why ARQT stock offers growth ...

Kaz Crossley has shared the important reason for her new cropped hair, she has been living with alopecia and shaved her head for charity. The influencer, first appeared on Love Island back in 2018 ...